North Korea troops partially withdraw from frontline in Russia’s Kursk after weeks of heavy losses
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
The tech world’s established order was upended this week by an unlikely disruptor: a small Chinese AI startup whose breakthrough has rattled Silicon Valley giants and sent shockwaves through global ...
N.G.R. Prasad, the workers’ lawyer, argued in court that the Registrar could not indefinitely delay the decision. Speaking to Frontline in October 2024, Muthukumar said, “This goes beyond money or ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Languages: English. North Korean troops have pulled back from at least one section of the frontline in the Kursk region of Russia, according to members of Ukraine's military. Sky News on Monday ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Hosted on MSN26d
Russia-Ukraine war: Frontline update as of January 24Frontline situation In the Kharkiv direction, Ukrainian defenders repelled two enemy assaults near Vovchansk. In the Kupiansk direction, the enemy launched 13 assaults on our defenders' positions ...
People walk with belongings after crossing the Oskil River bridge while fleeing the frontline town of Kupiansk, Kharkiv region, on September 24, 2022, amid Russia's military invasion on Ukraine. - In ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback